These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31112124)

  • 21. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Americans' access to prescription drugs stabilizes, 2007-2010.
    Boukus ER; Carrier ER
    Track Rep; 2011 Dec; (27):1-5. PubMed ID: 22180943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative Therapies as a Substitute for Costly Prescription Medications: Results from the 2011 National Health Interview Survey.
    Wang CC; Kennedy J; Wu CH
    Clin Ther; 2015 May; 37(5):1022-30. PubMed ID: 25748291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of health reform on young adult prescription medication utilization.
    Pakyz A; Wang H; Cunningham P
    Am J Manag Care; 2017 Nov; 23(11):670-676. PubMed ID: 29182353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015.
    Tang W; Xie J; Kong F; Malone DC
    Value Health; 2019 Aug; 22(8):871-877. PubMed ID: 31426927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G; Weiss RC
    Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.
    Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM
    Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers.
    Tibuakuu M; Okunrintemi V; Jirru E; Echouffo Tcheugui JB; Orimoloye OA; Mehta PK; DeFilippis AP; Blaha MJ; Michos ED
    JAMA Netw Open; 2019 May; 2(5):e194585. PubMed ID: 31125108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay.
    Groves S; Cohen D; Alam MF; Dunstan FD; Routledge PA; Hughes DA; Myles S
    Int J Pharm Pract; 2010 Dec; 18(6):332-40. PubMed ID: 21054593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.
    Morgan SG; Lee A
    BMJ Open; 2017 Jan; 7(1):e014287. PubMed ID: 28143838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.
    Sensharma A; Yabroff KR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):263-277. PubMed ID: 30628493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in Drug Pricing After Drug Shortages in the United States.
    Hernandez I; Sampathkumar S; Good CB; Kesselheim AS; Shrank WH
    Ann Intern Med; 2019 Jan; 170(1):74-76. PubMed ID: 30242373
    [No Abstract]   [Full Text] [Related]  

  • 38. Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015.
    Watanabe JH; Chau DL; Hirsch JD
    J Am Geriatr Soc; 2018 Aug; 66(8):1621-1624. PubMed ID: 29972589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. US lawmakers seek cuts in prescription drug prices.
    Jaffe S
    Lancet; 2019 Mar; 393(10175):975-976. PubMed ID: 30860040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.